表紙
市場調査レポート

中国の組織工学による代用皮膚市場の将来展望

China Tissue Engineered - Skin Substitutes Market Outlook to 2020

発行 GlobalData 商品コード 317777
出版日 ページ情報 英文 41 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
中国の組織工学による代用皮膚市場の将来展望 China Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日: 2014年10月27日 ページ情報: 英文 41 Pages
概要

当レポートでは、中国における、組織工学(再生医療)を用いた代用皮膚市場の現状と将来見通しについて分析し、全体的な市場規模(金額・数量ベース)の実績値・予測値や、個別分野−−生物学的代用皮膚(培養皮膚)、自家移植片(細胞/無細胞)、合成/生合成代用皮膚、異種移植片など−−の詳細動向、市場価格の動向、市場シェア(流通チャネル別・企業別)、主要企業の概略と戦略などを調査しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの問題意識
  • 組織工学による代用皮膚市場の分類
  • 分析対象の定義

第3章 中国の組織工学による代用皮膚市場

  • 市場規模の実績値(金額ベース、過去9年間分)
  • 市場規模の予測値(金額ベース、今後8年間分)
    • 生物学的代用皮膚の市場規模:実績値(金額ベース、過去9年間分)
    • 生物学的代用皮膚の市場規模:予測値(金額ベース、今後8年間分)
    • 自家移植片の市場規模:実績値(金額ベース、過去9年間分)
    • 自家移植片の市場規模:予測値(金額ベース、今後8年間分)
  • 市場規模の実績値(数量ベース、過去9年間分)
  • 市場規模の予測値(数量ベース、今後8年間分)
    • 生物学的代用皮膚の市場規模:実績値(数量ベース、過去9年間分)
    • 生物学的代用皮膚の市場規模:予測値(数量ベース、今後8年間分)
    • 自家移植片の市場規模:実績値(数量ベース、過去9年間分)
    • 自家移植片の市場規模:予測値(数量ベース、今後8年間分)
  • 平均価格の動向(通算16年間分)
  • 流通チャネル別の市場シェア(金額ベース)
  • 企業別の市場シェア(金額ベース)

第4章 主要企業の概要

  • National Tissue Engineering Research Center
  • Integra LifeSciences Holdings Corporation
  • Smith. Nephew Plc
  • Covidien plc
  • BSN medical GmbH

第5章 付録

図表一覧

目次
Product Code: GDMECC0944DB

GlobalData's new report, "China Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the China Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the China Tissue Engineered - Skin Substitutes.
  • Key players covered include National Tissue Engineering Research Center., Integra LifeSciences Holdings Corporation and Smith & Nephew Plc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered. Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered. Skin Substitutes Market, China

  • 3.1. Tissue Engineered. Skin Substitutes Market, China, Revenue ($m), 2005-2013
  • 3.2. Tissue Engineered. Skin Substitutes Market, China, Revenue ($m), 2013-2020
    • 3.2.1. Biologic Skin Substitutes Market, China, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Biologic Skin Substitutes Market, China, Revenue ($m), by Segment, 2013-2020
    • 3.2.3. Allograft Market, China, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.4. Allograft Market, China, Revenue ($m), by Sub Segment, 2013-2020
  • 3.3. Tissue Engineered. Skin Substitutes Market, China, Volume (Units), 2005-2013
  • 3.4. Tissue Engineered. Skin Substitutes Market, China, Volume (Units), 2013-2020
    • 3.4.1. Biologic Skin Substitutes Market, China, Volume (Units), by Segment, 2005-2013
    • 3.4.2. Biologic Skin Substitutes Market, China, Volume (Units), by Segment, 2013-2020
    • 3.4.3. Allograft Market, China, Volume (Units), by Sub Segment, 2005-2013
    • 3.4.4. Allograft Market, China, Volume (Units), by Sub Segment, 2013-2020
  • 3.5. Tissue Engineered. Skin Substitutes Market, China, Average Price ($), 2005-2020
  • 3.6. Tissue Engineered. Skin Substitutes Market, China, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Tissue Engineered. Skin Substitutes Market, China, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in China, Tissue Engineered. Skin Substitutes Market

  • 4.1. National Tissue Engineering Research Center
    • 4.1.1. Company Overview
  • 4.2. Integra LifeSciences Holdings Corporation
    • 4.2.1. Company Overview
  • 4.3. Smith. Nephew Plc
    • 4.3.1. Company Overview
  • 4.4. Covidien plc
    • 4.4.1. Company Overview
  • 4.5. BSN medical GmbH
    • 4.5.1. Company Overview

5. Appendix

  • 5.1. Research Methodology
    • 5.1.1. Coverage
    • 5.1.2. Secondary Research
    • 5.1.3. Primary Research
    • 5.1.4. Market Modeling and Forecasting
    • 5.1.5. Company Share Analysis
    • 5.1.6. Distribution Share Analysis
  • 5.2. Expert Panel
  • 5.3. GlobalData Consulting
  • 5.4. Contact Us
  • 5.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Biologic Skin Substitutes(Allograft) Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 5: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Historic, 2005-2013
  • Table 6: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Forecast, 2013-2020
  • Table 7: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Historic, 2005-2013
  • Table 8: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Forecast, 2013-2020
  • Table 9: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Historic, 2005-2013
  • Table 10: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Forecast, 2013-2020
  • Table 11: Allograft Market, China, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 12: Allograft Market, China, Volume (Units), by Sub Segment, Forecast, 2013-2020
  • Table 13: Tissue Engineered - Skin Substitutes Market, China, Average Price ($), Historic, 2005-2013
  • Table 14: Tissue Engineered - Skin Substitutes Market, China, Average Price ($), Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, China, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, China, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 17: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Tissue Engineered - Skin Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Biologic Skin Substitutes (Allograft) Market, China, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 5: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Historic, 2005-2013
  • Figure 6: Allograft Market, China, Revenue ($m), by Sub Segment, USD Constant, Forecast, 2013-2020
  • Figure 7: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Historic, 2005-2013
  • Figure 8: Tissue Engineered - Skin Substitutes Market, China, Volume (Units), Forecast, 2013-2020
  • Figure 9: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Historic, 2005-2013
  • Figure 10: Biologic Skin Substitutes (Allograft) Market, China, Volume (Units), Forecast, 2013-2020
  • Figure 11: Allograft Market, China, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Figure 12: Allograft Market, China, Volume (Units), by Sub Segment, Forecast, 2013-2020
  • Figure 13: Tissue Engineered - Skin Substitutes Market, China, Company Share (%), 2013
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top